Sanofi (SAN) PT Set at €82.00 by Goldman Sachs Group, Inc. (The)

Sanofi (EPA:SAN) has been given a €82.00 ($96.47) target price by research analysts at Goldman Sachs Group, Inc. (The) in a research report issued to clients and investors on Friday, November 3rd. The firm presently has a “neutral” rating on the stock. Goldman Sachs Group, Inc. (The)’s price objective would indicate a potential upside of 6.90% from the stock’s previous close.

SAN has been the topic of several other research reports. J P Morgan Chase & Co set a €90.00 ($105.88) price target on Sanofi and gave the company a “neutral” rating in a research note on Tuesday, August 1st. S&P Global set a €90.00 ($105.88) target price on Sanofi and gave the company a “neutral” rating in a research report on Monday, July 31st. Sanford C. Bernstein set a €90.00 ($105.88) target price on Sanofi and gave the company a “neutral” rating in a research report on Monday, July 31st. Jefferies Group LLC set a €87.00 ($102.35) price objective on Sanofi and gave the stock a “neutral” rating in a report on Thursday, August 24th. Finally, BNP Paribas set a €85.00 ($100.00) price objective on Sanofi and gave the stock a “neutral” rating in a report on Tuesday, September 12th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of €87.24 ($102.63).

Shares of Sanofi (EPA SAN) traded up €0.27 ($0.32) on Friday, reaching €76.71 ($90.25). The company’s stock had a trading volume of 2,120,000 shares, compared to its average volume of 1,940,000. Sanofi has a 52-week low of €73.39 ($86.34) and a 52-week high of €92.97 ($109.38).

ILLEGAL ACTIVITY WARNING: “Sanofi (SAN) PT Set at €82.00 by Goldman Sachs Group, Inc. (The)” was first reported by BBNS and is the sole property of of BBNS. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://baseballnewssource.com/markets/sanofi-sa-san-pt-set-at-82-00-by-goldman-sachs-group-inc-the-2/1754373.html.

About Sanofi

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Analyst Recommendations for Sanofi (EPA:SAN)

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.